I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Lutzky, Jose
40
results:
Articles (Online) X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/..:
Larkin, James
;
Del Vecchio, Michele
;
Mandalá, Mario
...
Clinical Cancer Research. 29 (2023) 17 - p. 3352-3361 , 2023
Link:
https://doi.org/10.1158/..
?
2
Phase 1b study of intravenous coxsackievirus A21 (V937) and..:
Lutzky, Jose
;
Sullivan, Ryan J.
;
Cohen, Justine V.
...
Journal of Cancer Research and Clinical Oncology. 149 (2023) 9 - p. 6059-6066 , 2023
Link:
https://doi.org/10.1007/..
?
3
Omission of Completion Lymph Node Dissection in Sentinel No..:
Kesmodel, Susan B.
;
Kronenfeld, Joshua P.
;
Zhao, Wei
...
Annals of Surgical Oncology. 30 (2023) 12 - p. 7671-7685 , 2023
Link:
https://doi.org/10.1245/..
?
4
ASO Visual Abstract: Omission of Completion Lymph Node Diss..:
Kesmodel, Susan B.
;
Kronenfeld, Joshua P.
;
Zhao, Wei
...
Annals of Surgical Oncology. 30 (2023) 12 - p. 7686-7687 , 2023
Link:
https://doi.org/10.1245/..
?
5
Multi-omic profiling reveals discrepant immunogenic propert..:
In, Gino K.
;
Ribeiro, Jennifer R.
;
Yin, Jun
...
npj Precision Oncology. 7 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
6
Safety, tolerability and efficacy of agonist anti-CD27 anti..:
Sanborn, Rachel E
;
Pishvaian, Michael J
;
Callahan, Margaret K
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 8 - p. e005147 , 2022
Link:
https://doi.org/10.1136/..
?
7
Adjuvant crizotinib in high-risk uveal melanoma following d..:
Khan, Shaheer
;
Lutzky, Jose
;
Shoushtari, Alexander N.
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
8
Clinical activity of PD-1 inhibition in the treatment of lo..:
In, Gino Kim
;
Nallagangula, Aparna
;
Choi, Jacob Seung
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 5 - p. e004839 , 2022
Link:
https://doi.org/10.1136/..
?
9
Recognising immunotherapy-induced meningoencephalitis: a ca..:
Grunhut, Joel
;
Brown, Shimron
;
Lutzky, Jose
.
BMJ Case Reports. 15 (2022) 7 - p. e249411 , 2022
Link:
https://doi.org/10.1136/..
?
10
Author Correction: PD-L1 blockade in combination with inhib..:
Ribas, Antoni
;
Algazi, Alain
;
Ascierto, Paolo A.
...
Nature Communications. 12 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1038/..
?
11
Multicenter, double-blind, placebo-controlled trial of sevi..:
Slingluff, Craig L
;
Lewis, Karl D
;
Andtbacka, Robert
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 10 - p. e003272 , 2021
Link:
https://doi.org/10.1136/..
?
12
Impact of Medicaid Expansion Status and Race on Metastatic ..:
Fabregas, Jesus C.
;
Carter, Benjamin T.
;
Lutzky, Jose
..
Journal of Racial and Ethnic Health Disparities. 9 (2021) 6 - p. 2291-2299 , 2021
Link:
https://doi.org/10.1007/..
?
13
Adjuvant nivolumab for stage III/IV melanoma: evaluation of..:
Mandalá, Mario
;
Larkin, James
;
Ascierto, Paolo A
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 8 - p. e003188 , 2021
Link:
https://doi.org/10.1136/..
?
14
PD-L1 blockade in combination with inhibition of MAPK oncog..:
Ribas, Antoni
;
Algazi, Alain
;
Ascierto, Paolo A.
...
Nature Communications. 11 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1038/..
?
15
A phase 2 study of glembatumumab vedotin, an antibody‐drug ..:
Ott, Patrick A.
;
Pavlick, Anna C.
;
Johnson, Douglas B.
...
Cancer. 125 (2019) 7 - p. 1113-1123 , 2019
Link:
https://doi.org/10.1002/..
1-15